5//SEC Filing
ARONSTEIN MICHAEL 5
Accession 0001469709-22-000007
CIK 0001085596other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:41 PM ET
Size
21.3 KB
Accession
0001469709-22-000007
Insider Transaction Report
Form 5
AngioGenex, Inc.AGGX
ARONSTEIN MICHAEL
Director10% OwnerOther
Transactions
- Award
Common Stock
2020-08-05$10000.00/sh+50,000$500,000,000→ 6,130,555 total - Award
Common Stock
2020-10-08$10000.00/sh+55,555$555,550,000→ 6,130,555 total - Award
Common Stock
2021-08-31$100000.00/sh+750,000$75,000,000,000→ 7,507,827 total - Award
Stock Option
2021-09-02$0.13/sh+2,000,000$260,000→ 5,000,000 totalExercise: $0.13From: 2021-09-02Exp: 2026-09-02→ Common Stock (2,000,000 underlying) - Award
Common Stock
2019-10-23$25000.00/sh+250,000$6,250,000,000→ 6,000,000 total - Award
Common Stock
2019-12-30$25000.00/sh+250,000$6,250,000,000→ 6,000,000 total - Award
Common Stock
2020-03-03$5000.00/sh+25,000$125,000,000→ 6,130,555 total - Award
Common Stock
2021-03-02$100000.00/sh+400,000$40,000,000,000→ 7,507,827 total - Award
Common Stock
2021-06-08$25000.00/sh+227,272$5,681,800,000→ 7,507,827 total - Award
Stock Option
2019-01-15$0.04/sh+3,000,000$105,000→ 3,000,000 totalExercise: $0.35From: 2020-01-15Exp: 2024-01-15→ Common Stock (3,000,000 underlying) - Award
Convertible Note
2021-11-02$0.25/sh+240,000$60,000→ 5,240,000 totalExercise: $25.00From: 2021-11-02Exp: 2023-10-31→ Common Stock (240,000 underlying)
Documents
Issuer
AngioGenex, Inc.
CIK 0001085596
Entity typeother
Related Parties
1- filerCIK 0001728637
Filing Metadata
- Form type
- 5
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:41 PM ET
- Size
- 21.3 KB